Comparative Pharmacology
Head-to-head clinical analysis: FERAHEME versus SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FERAHEME versus SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE.
FERAHEME vs SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ferumoxytol is a superparamagnetic iron oxide nanoparticle coated with a semisynthetic carbohydrate shell. It serves as a source of iron for hemoglobin synthesis and replenishes iron stores. The iron core is processed intracellularly to release iron, which is then incorporated into hemoglobin or stored as ferritin. The carbohydrate shell is metabolized and eliminated.
Sodium ferric gluconate complex in sucrose provides elemental iron for hemoglobin synthesis and replenishes iron stores in iron-deficient states. The iron complex is taken up by the reticuloendothelial system, where iron is released and bound to transferrin for erythropoiesis.
510 mg intravenously once, followed by a second 510 mg dose 3 to 8 days later, not exceeding 1020 mg per course.
125 mg elemental iron (10 mL) intravenously over at least 10 minutes, given at sequential dialysis sessions to a cumulative total dose of 1000 mg elemental iron.
None Documented
None Documented
Terminal half-life of ferumoxytol (iron core) is approximately 14-21 hours; for the intact nanoparticle (carbohydrate shell), half-life is about 15 hours. Clinically, iron is continuously released and incorporated, extending effects beyond half-life.
Terminal elimination half-life is approximately 6 hours for the iron-sucrose complex; clinical context: indicates redistribution and utilization for erythropoiesis, with full hemoglobin correction over weeks.
Renal: minimal (<1% as intact drug); primarily degraded endogenously with iron incorporated into hemoglobin; fecal/biliary elimination of unabsorbed iron is negligible.
Primarily excreted via feces (93%) as non-absorbed iron; renal elimination of absorbed iron is minimal (<1%).
Category C
Category C
Iron Supplement
Iron Supplement